Feature Story

Global scientific leaders explore strategies to achieve the 90-90-90 target

22 July 2015

Leading HIV researchers describing results from multiple clinical trials in sub-Saharan Africa report that innovative service delivery models are achieving results across the HIV treatment cascade that approach or exceed the 90–90–90 target.

Study results were presented at an all-day workshop hosted by the British Columbia Centre for Excellence in HIV/AIDS and the Division of AIDS at the University of British Columbia, prior to the opening of the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention in Vancouver, Canada. The studies are being undertaken in a number of high-burden countries in sub-Saharan Africa, including Botswana, Kenya, Malawi, South Africa, Swaziland, Uganda and Zambia.

“These exceptional clinical trial results show yet again how innovation is driving progress in the AIDS response,” said UNAIDS Executive Director Michel Sidibé. “The results demonstrate that the 90–90–90 target is more than a dream. It is entirely feasible.”

Diane Havlir, of the University of California, San Francisco, presented interim results from the Sustainable East Africa Research for Community Health (SEARCH) trial in more than 30 rural communities in Kenya and Uganda. Having enrolled more than 334 000 people, the SEARCH trial is evaluating a multicomponent programme, including use of community-centred, multidisease campaigns to provide HIV testing and link HIV-positive individuals to immediate initiation of antiretroviral therapy.

At a population level, the SEARCH programme has achieved 90% knowledge of HIV status. Among participants living with HIV, more than 90% of people in Uganda and 83% in Kenya are receiving antiretroviral therapy. At 24 weeks, 92% of trial participants who have initiated antiretroviral therapy have achieved viral suppression.

Similarly encouraging, although preliminary, results were reported from the PopART trial by Richard Hayes of the London School of Hygiene and Tropical Medicine. Working in 21 communities, the trial is evaluating a combination HIV prevention package that includes repeated rounds of community-level HIV testing and immediate initiation of antiretroviral therapy for all people who are diagnosed HIV-positive. Among more than 115 000 community members enumerated in the trial, 90% of all men living with HIV and 92% of all women living with HIV were aware of their HIV status following the PopART programme. Among people with an HIV diagnosis, 62% of men and 65% of women were receiving antiretroviral therapy, highlighting the need to further strengthen linkage to care for people living with HIV. Data on rates of viral suppression among PopART participations will be available next year.

Max Essex, of the Harvard University School of Public Health, presented baseline findings for the Botswana Combination Prevention Protocol. Mr Essex and his colleagues have found that 79% of all people living with HIV in Botswana knew their HIV status as of mid-2015, 86% of adults who have been diagnosed with HIV were receiving antiretroviral therapy and 96% of people receiving antiretroviral therapy had achieved viral suppression.

Comparably impressive results have been achieved by a Médicins Sans Frontières (MSF) programme in the District of Chiradzulu in Malawi, according to David Maman of MSF. In Chiradzulu, 77% of all people living with HIV know their HIV status, 84% of people with an HIV diagnosis are receiving antiretroviral therapy and 91% of people receiving antiretroviral therapy have achieved viral suppression.

François Dabis, of the Bordeaux School of Public Health, described preliminary results from a separate trial in the Hlabisa district in KwaZulu-Natal, South Africa, of a test-and-treat initiative that includes six-month rounds of community-level testing and establishment of antiretroviral treatment sites in all communities in the study. Among more than 26 000 people in the study communities, 85% know their HIV status. Among HIV-diagnosed people reached by the programme, 86% are receiving antiretroviral therapy. Study results indicate that linkage to care remains suboptimal and an important focus of further work and innovation.

Several important themes emerged from these study findings. Researchers emphasized the importance and value of engaging and collaborating with local communities in developing programme approaches tailored to local needs and circumstances. Most of the studies have also taken multidisciplinary approaches to the development, monitoring and evaluation of programmes, involving social scientists, economists and community representatives as well as clinicians and biostatisticians.

Feature Story

Vancouver delegates call for greater innovation in HIV diagnostics

22 July 2015

Innovation in HIV diagnostics is urgently needed if the world hopes to achieve the 90–90–90 target for access to antiretroviral therapy, leading scientific experts advised this week. The call for intensified effort and innovation on HIV diagnostics occurred during two sessions at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, held in Vancouver, Canada.

“It is clear that we can’t accept business as usual when it comes to HIV diagnostics,” said UNAIDS Deputy Executive Director Luiz Loures, who moderated a special satellite session on enhancing diagnostic access. “We must do things differently if we are to reach the 90–90–90 target.”

Global experts focused on three key diagnostic challenges: ensuring timely diagnosis of HIV among children, rapidly increasing knowledge of HIV status among adults living with HIV and scaling up essential viral load testing. These three focus areas are key priorities for the Diagnostics Access Initiative, a multi-stakeholder global initiative that aims to fully leverage the potential of laboratory medicine to lay the groundwork to end the AIDS epidemic as a public health threat.

Diagnosing children living with HIV

Unlike adults, who can be diagnosed with HIV through a simple antibody test, very young children require more expensive molecular tests, which use centralized laboratories that are remote from clinical sites. This creates substantial delays in diagnosing HIV-exposed children and also increases both costs and the risks that specimens or results will be lost. Even when early infant diagnostic services are available, many HIV-exposed children only receive their HIV test results after the time when peak mortality occurs, at six to eight weeks old, according to Trevor Peter, of the Clinton Health Access Initiative (CHAI).

Relatively simple, point-of-care diagnostic tests for early infant diagnosis are now emerging, Mr Peter reported, and these will need to be rapidly scaled up. In addition, mobile health technologies have the potential to reduce delays in the communication of test results and help ensure that test results for HIV-exposed children are actually received at the clinical site. At the Vancouver conference, UNAIDS and its partners in the Diagnostics Access Initiative announced with Roche Diagnostics a 35% decline in the global price for early infant diagnostic testing.

Ensuring 90% knowledge of HIV status among adolescents and adults living with HIV

UNAIDS sponsored a separate session at the conference on democratizing HIV testing to reach the 90–90–90 target. Joseph Amon of Human Rights Watch advised that all people should feel empowered to choose where, when and how they want to be tested for HIV. Consistent with this human rights approach, there is growing interest in HIV self-testing tools.

New international guidelines on HIV testing services, launched by the World Health Organization (WHO) in Vancouver this week, indicate that WHO envisages widespread access to self-testing as an important component of a comprehensive HIV testing effort. Several countries in different regions currently allow HIV self-testing, but most countries have yet to adapt their laws and regulatory frameworks to permit it.

The new WHO guidelines on HIV self-testing emphasize the importance of moving testing access closer to communities. In particular, the new guidelines recommend steps to enable lay workers to administer HIV tests. Results from the Sustainable East Africa Research for Community Health (SEARCH) trial in more than 30 rural communities in Kenya and Uganda indicate that population-level knowledge of HIV status approaching or exceeding 90% can be achieved through community-owned, multidisease testing campaigns.

Presenting modelling work, John Stover of Avenir Health said that 90% knowledge of HIV status is achievable more broadly through a strategic combination of testing strategies, such as provider-initiated testing in diverse health settings, outreach to key populations, fixed centres for HIV testing and counselling, and various community-based approaches, such as HIV self-testing, mobile testing and door-to-door, home-based efforts.

Ensuring universal access to viral load testing

Conference participants also heard urgent calls to expand access to viral load testing. Not only is access to viral load testing essential for monitoring the 90-90-90 target, but viral load testing is an essential clinical tool to detect early treatment failure and permit intervention to improve treatment adherence. However, projections by CHAI indicate that current trends in the uptake of viral load testing are insufficient to ensure achievement of the 90–90–90 target.

During the diagnostics-focused sessions, several ways forward were suggested to close the viral load testing gap. Partners in the Diagnostics Access Initiative, along with the Government of South Africa, last year concluded an agreement with Roche Diagnostics to reduce the price of viral load testing by 40% worldwide. In addition, steps need to be taken to maximize the effective use of the viral load platforms that presently exist, as many viral load technologies are severely under-utilized at present.

Feature Story

UNFPA, WHO and UNAIDS: Position statement on condoms and the prevention of HIV, other sexually transmitted infections and unintended pregnancy

07 July 2015

Condoms are a critical component in a comprehensive and sustainable approach to the prevention of HIV and other sexually transmitted infections (STIs) and are effective for preventing unintended pregnancies. In 2013, an estimated 2.1 million people became newly infected with HIV[i] and an estimated 500 million people acquired chlamydia, gonorrhoea, syphilis or trichomoniasis.[ii] In addition, every year more than 200 million women have unmet needs for contraception,[iii] leading to approximately 80 million unintended pregnancies.[iv] These three public health priorities require a decisive response using all available tools, with condoms playing a central role.

Male and female condoms are the only devices that both reduce the transmission of HIV and other sexually transmitted infections (STIs) and prevent unintended pregnancy.

Laboratory studies show that condoms provide an impermeable barrier to particles the size of sperm and STI pathogens, including HIV.[v] [vi] Condoms, when used consistently and correctly, are highly effective in preventing the sexual transmission of HIV. Research among serodiscordant couples (where one partner is living with HIV and the other is not) shows that consistent condom use significantly reduces the risk of HIV transmission both from men to women and women to men[vii] [viii] [ix] Consistent and correct use of condoms also reduces the risk of acquiring other STIs and associated conditions, including genital warts and cervical cancer.[x] With a failure rate of about 2% when used consistently and correctly, condoms are very effective at preventing unintended pregnancy.[xi] [xii]

Condoms have played a decisive role in HIV, STI and pregnancy prevention efforts in many countries.

Condoms have helped to reduce HIV transmission and curtailed the broader spread of HIV in settings where the epidemic is concentrated in specific populations.[xiii] Distribution of condoms has been shown to reduce rates of HIV and other STIs in sex workers[xiv] [xv] [xvi] and men who have sex with men.[xvii] In India[xviii] [xix] and Thailand[xx] increased condom distribution to sex workers and their clients in combination with other prevention interventions were associated with reductions of transmission of both HIV and other STIs. Zimbabwe[xxi] and South Africa are two high-prevalence countries where increased condom use was found to contribute to reductions in HIV incidence.[xxii]

A recent global modelling analysis estimated that condoms have averted around 50 million new HIV infections since the onset of the HIV epidemic.[xxiii] For 2015, 27 billion condoms expected to be available globally through the private and public sector will provide up to an estimated 225 million couple years protection from unintended pregnancies.[xxiv] [xxv]

Condoms remain a key component of high-impact HIV prevention programmes.

Recent years have seen major scientific advances in other areas of HIV prevention. Biomedical interventions including antiretroviral therapy (ART) for people living with HIV can substantially reduce HIV transmission. While the success of ART may alter the perception of risk associated with HIV, studies have shown that people living with HIV who are enrolled in treatment programmes and have access to condoms report higher condom use compared to those not enrolled.[xxvi]

Condom use by people on HIV treatment and among serodiscordant couples is strongly recommended. [xxvii] Only when sustained viral suppression is confirmed and very closely monitored, and when the risk of other STIs and unintended pregnancy is low, it may be safe not to use condoms.[xxviii] [xxix] [xxx]

Oral pre-exposure prophylaxis (PrEP)—where antiretroviral drugs are used by HIV-negative people to reduce their risk of acquiring HIV—is also effective in preventing HIV acquisition, but is not yet widely available and is currently only recommended as an additional tool for people at higher risk, such as people in sero-discordant relationships, men who have sex with men and female sex workers, in particular in circumstances in which consistent condom use is difficult to achieve.[xxxi] Voluntary medical male circumcision (VMMC) can reduce the risk of HIV acquisition by 60% among men, but because protection is only partial, should be supplemented with condom use. [xxxii]

Hence, condom use remains complementary to all other HIV prevention methods, including ART and PrEP, in particular when other STIs and unintended pregnancy are of concern. The roll-out of large-scale HIV testing and treatment, VMMC and STI control programmes, and efforts to increase access to affordable contraception all offer opportunities for integrating condom promotion and distribution.

Quality-assured condoms must be readily available universally, either free or at low cost.

To ensure safety, efficacy and effective use, condoms must be manufactured according to the international standards, specifications and quality assurance procedures established by WHO, UNFPA and the International Organization for Standardization[xxxiii] [xxxiv] and made available either free or at affordable cost. Condom use in resource-limited settings is more likely when people can access them at no cost or at subsidized prices.[xxxv] [xxxvi]

Most countries with high HIV rates continue to heavily depend on donor support for condoms. In 2013, only about 10 condoms were made available to every man aged 15-64, and on average only one female condom per eight women in sub- Saharan Africa. HIV prevention programmes need to ensure that a sufficient number and variety of quality assured condoms are accessible to people who need them, when they need them. Adequate supplies of water based-lubricants also need to be provided to minimize condom usage failure, especially for anal sex, vaginal dryness and in the context of sex work.[xxxvii]

Despite generally increasing trends in condom use over the past two decades, substantial variations and gaps remain. Reported condom use at last sex with non-regular partners ranges from 80% use by men in Namibia and Cambodia to less than 40% usage by men and women in other countries, including some highly affected by HIV. Similarly, among young people aged 15 to 24 years, condom use at last sex varies from more than 80% in some Latin American and European countries to less than 30% in some West African countries.[xxxviii] This degree of variation highlights the need for countries to set ambitious national and subnational targets and that in many settings there are important opportunities for strengthening demand and supply of condoms.

Programmes promoting condoms must address stigma and gender-based and socio-cultural factors that hinder effective access and use of condoms.

Effective condom promotion should be tailored for people at increased risk of HIV and other STIs and/or unintended pregnancy, including young people, sex workers and their clients, injecting drug users and men who have sex with men. Many young women and girls, especially those in long-term relationships and sex workers, do not have the power and agency to negotiate the use of condoms, as men are often resistant to using condoms. Within relationships, the use of condoms may be taken to signal a lack of trust or intimacy.

However, few programmes adequately address the barriers that hinder access and use of condoms by young people,[xxxix] key populations[xl] and men and women in relationships. In some contexts, sex workers are forced to have unprotected sex by their clients.[xli] [xlii] and carrying condoms is criminalized and used as evidence by police to harass or to prove involvement in sex work[xliii] [xliv] These practices undermine HIV prevention efforts and governments should take actions to end these human rights violations.[xlv] Condom programmes should ensure that condoms and lubricants are widely available and that young people and key populations have the knowledge, skills and empowerment to use them correctly and consistently.[xlvi] Condoms should also be made available in prisons and closed settings,[xlvii] [xlviii] and in humanitarian crises situations.[xlix]

Adequate investment in and further scale up of condom promotion is required to sustain responses to HIV, other STIs, and unintended pregnancy.

Despite the low cost of condoms, international funding for condom procurement in sub-Saharan Africa has stagnated in recent years.[l] Collective actions at all levels are needed to support the efforts of countries that depend on external assistance for condom procurement, promotion, and distribution and to increase domestic funding and private sector investment in condom distribution and promotion.[li]

Although condoms are part of most national HIV, STI and reproductive health programmes, condoms have not been consistently distributed nor promoted proactively enough.[lii] National condom distribution and sales can be strengthened by applying a total market approach that combines public sector distribution, social marketing and private sector sales.[liii] [liv] Administrative barriers that prevent programmes and organizations from providing sufficient quantities of condoms for distribution need to be removed. In high-HIV prevalence locations condom promotion and distribution should become systematically integrated in community outreach and service delivery, and in broader health service provision.


[i] UNAIDS. 2014. World AIDS Day Report 2014.

[ii] WHO, Dept. of Reproductive Health and Research. Global incidence and prevalence of selected curable sexually transmitted infections.

[iii] UNFPA/Guttmacher Institute. 2012. Adding It Up: Costs and Benefits of Contraceptive Services.

[iv] Sedgh G et al. Intended and Unintended Pregnancies Worldwide in 2012 and Recent Trends. Studies in Family Planning, 2014, Vol 45. 3, 301–314, 2014.

[v] Carey RF et al. Effectiveness of latex condoms as a barrier to human immunodeficiency virus-sized particles under conditions of simulated use. Sex Transm Dis 1992;19:230-4.

[vi] WHO/UNAIDS. 2001. Information note on Effectiveness of Condoms in Preventing Sexually Transmitted Infections including HIV.

[vii] Holmes K et al. Effectiveness of condoms in preventing sexually transmitted infections. Bulletin of the World Health Organization, 2004, 82 (6).

[viii] Weller S et al. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev. 2002;(1):CD003255.

[ix] Smith DK et al. Condom effectiveness for HIV prevention by consistency of use among men who have sex with men in the United States. J Acquir Immune Defic Syndr. 2015 Mar 1;68(3):337-44.

[x] Also see: http://www.cdc.gov/condomeffectiveness/brief.html

[xi] Trussell J. Contraceptive efficacy, in: Hatcher RA et al., eds., Contraceptive Technology: Twentieth Revised Edition, New York: Ardent Media, 2011, pp. 779–863.

[xii] Kost K et al. Estimates of contraceptive failure from the 2002 National Survey of Family Growth. Contraception, 2008; 77:10-21.

[xiii] Hanenberg RS et al. Impact of Thailand's HIV-control programme as indicated by the decline of sexually transmitted diseases. Lancet, 1994, 23;344(8917): 243-5.

[xiv] Ghys PD et al. Increase in condom use and decline in HIV and sexually transmitted diseases among female sex workers in Abidjan, Cote d’Ivoire, 1991–1998. AIDS, 2002, 16(2):251–258.

[xv] Levine WC et al. Decline in sexually transmitted disease prevalence in female Bolivian sex workers: impact of an HIV prevention project. AIDS, 1998, 12(14):1899–1906.

[xvi] Fontanet AL et al. Protection against sexually transmitted diseases by granting sex workers in Thailand the choice of using the male or female condom: results from a randomized controlled trial. AIDS, 1998, 12(14):1851–1859.

[xvii] Smith D et al. Condom efficacy by consistency of use among MSM: US. 20th Conference on Retroviruses and Opportunistic Infections, Atlanta, abstract 32, 2013.

[xviii] Boily M-C et al. Positive impact of a large-scale HIV prevention programme among female sex workers and clients in South India. AIDS, 2013, 27:1449–1460.

[xix] Rachakulla HK et al. Condom use and prevalence of syphilis and HIV among female sex workers in Andhra Pradesh, India - following a large-scale HIV prevention intervention. BMC Public Health, 2011; 11 (Suppl 6): S1.

[xx] UNAIDS. 2000. Evaluation of the 100% Condom Programme in Thailand, UNAIDS Case Study.

[xxi] Halperin DT et al. A surprising prevention success: Why did the HIV epidemic decline in Zimbabwe? PLoS Med. 2011. 8;8(2).

[xxii] Johnson LF et al. 2012. The effect of changes in condom usage and antiretroviral treatment coverage on human immunodeficiency virus incidence in South Africa: a model-based analysis, Journal of the Royal Society Interface. 2012, 7;9(72):1544-54.

[xxiii] Stover J. 2014. Presentation. UNAIDS Global Condom Meeting, Geneva, November 2014.

[xxiv] In line with standard assumptions, 120 condoms are required for 1 couple year of protection. Projected condom sales for 2015 cited based on: Global Industry Analysts. 2014. Global Condoms Market. May 2014.

[xxv] Stover J et al. Empirically based conversion factors for calculating couple-years of protection. Eval Rev. 2000 Feb; 24(1):3-46.

[xxvi] Kennedy C et al.  Is use of antiretroviral treatment (ART) associated with decreased condom use? A meta-analysis of studies from low- and middle-income countries (LMICs). July 2014 h International AIDS Conference. Melbourne, WEAC0104 - Oral Abstract Session.

[xxvii] Liu H et al. Effectiveness of ART and condom use for prevention of sexual HIV transmission in sero-discordant couples: a systematic review and meta-analysis. PLoS One. 2014 4;9(11):e111175.

[xxviii] Swiss AIDS Federation Advice Manual: Doing without condoms during potent ART. Swiss AIDS Federation, 2008.

[xxix] Fakoya A et al. British HIV Association, BASHH and FSRH guidelines for the management of the sexual and reproductive health of people living with HIV infection. HIV Medicine, 2008, 9: 681-720, 2008.

[xxx] Marks G et al. Time above 1500 copies: a viral load measure for assessing transmission risk of HIV-positive patients in care. AIDS 2015, 29:947–954.

[xxxi] WHO. 2015. Technical update on Pre-exposure Prophylaxis (PrEP), February 2015. WHO/HIV/2015.4.

[xxxii] WHO. 2007. New Data on Male Circumcision and HIV Prevention: Policy and Programme Implications. WHO/UNAIDS Technical Consultation on Male Circumcision and HIV Prevention: Research Implications for Policy and Programming Montreux, 6 – 8 March 2007 Conclusions and Recommendations.

[xxxiii] WHO, UNFPA and Family Health International. 2013.  Male Latex Condom: Specification, Prequalification and Guidelines for Procurement, 2010 revised April 2013.

[xxxiv] International Organisation for Standardisation. 2014. ISO 4074:2014 Natural rubber latex male condoms -- Requirements and test methods. http://www.iso.org/iso/catalogue_detail.htm?csnumber=59718.

[xxxv] Charania MR et al. Efficacy of Structural-Level Condom Distribution Interventions: A Meta-Analysis of U.S. and International Studies, 1998–2007. AIDS Behav, 2011, 15:1283–1297.

[xxxvi] Sweat MD et al. Effects of condom social marketing on condom use in developing countries: a systematic review and meta-analysis, 1990–2010. Bulletin of the World Health Organization 2012, 90:613- 622A. doi: 10.2471/BLT.11.094268.

[xxxvii] Use and procurement of additional lubricants for male and female condoms: WHO/UNFPA/FHI360 Advisory note. 2012.

[xxxviii]Source: Data from a database of Demographic and Health Surveys (DHS) available at statcompiler.com (verified January 2015).

[xxxix] Dusabe J, et al.  “There are bugs in condoms”: Tanzanian close-to-community providers’ ability to offer effective adolescent reproductive health services. J Fam Plann Reprod Health Care 2015;41:e2.

[xl] Key populations are defined groups who, due to specific higher-risk behaviours, are at increased risk of HIV irrespective of the epidemic type or local context. Also, they often have legal and social issues related to their behaviours that increase their vulnerability to HIV. These guidelines focus on five key populations: 1) men who have sex with men, 2) people who inject drugs, 3) people in prisons and other closed settings, 4) sex workers and 5) transgender people. In consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations. World Health Organization 2014.

[xli] Global Commission on HIV and the Law. Risks, Rights & Health. 2012

[xlii] UNAIDS. 2014. The Gap report.

[xliii] Open Society Foundations. 2012. Criminalizing condoms. How policing practices put sex workers and HIV services at risk in Kenya, Namibia, Russia, South Africa, the United States and Zimbabwe. http://www.opensocietyfoundations.org/reports/criminalizing-condoms.

[xliv] Bhattacharjya, M et al. The Right(s) Evidence – Sex Work, Violence and HIV in Asia: A Multi-Country Qualitative Study. Bangkok: UNFPA, UNDP and APNSW (CASAM). 2015.

[xlv] WHO; UNFPA; UNAIDS; NSWP; World Bank. 2013. Implementing comprehensive HIV/STI programmes with sex workers: practical approaches from collaborative intervention. 2013.

[xlvi] Vijayakumar G et al. A review of female-condom effectiveness: Patterns of use and impact on protected sex acts and STI incidence. International Journal of STD and AIDS, 2006, 17(10):652-659.

[xlvii] UNODC/WHO/UNAIDS. 2006. HIV/AIDS Prevention, Care, Treatment and Support in Prison Settings A Framework for an Effective National Response.

[xlviii] UNODC/ILO/UNDP/WHO/UNAIDS. 2012. Policy brief. HIV prevention, treatment and care in prisons and other closed settings: A comprehensive package of interventions.

[xlix] Inter-Agency Standing Committee (IASC). 2003. Guidelines for HIV/AIDS interventions in emergency settings. Task Force on HIV/AIDS in Emergency Settings.

[l] UNFPA. 2015. Contraceptives and condoms for family planning and STI/HIV prevention. External procurement support report 2013.

[li] Foss AM et al. A systematic review of published evidence on intervention impact on condom use in sub-Saharan Africa and Asia. Sex Transm Infect 2007, 83:510–516.

[lii] Fossgard IS et al. Condom availability in high risk places and condom use: a study at district level in Kenya, Tanzania and Zambia. BMC Public Health 2012, 12:1030.

[liii] UNFPA-PSI.  2013. Total Market Approach Case Studies Botswana, Lesotho, Mali, South Africa, Swaziland, Uganda. http://www.unfpa.org/publications/unfpa-psi-total-market-approach-case-studies

[liv] Barnes, J et al. 2015. Using Total Market Approaches in Condom Programs. Bethesda, MD: Strengthening Health Outcomes through the Private Sector Project, Abt Associates.

Feature Story

Promoting greater focus on HIV in humanitarian emergencies

06 July 2015

AIDS strategies and efforts must give greater priority to humanitarian emergencies and the millions of people affected by them, members of the UNAIDS governing body agreed at the thematic segment of the 36th meeting of the UNAIDS Programme Coordinating Board (PCB), which took place in Geneva, Switzerland, on 2 July.

New data presented at the thematic session by the Office of the United Nations High Commissioner for Refugees (UNHCR), the World Food Programme (WFP) and UNAIDS Secretariat estimate that of the 314 million people affected by humanitarian emergencies in 2013, 1.6 million people--or 1 in 22-- are living with HIV, and many thousands more are at risk.

“We are talking about incredible numbers of people and multiple layers of vulnerability. This is too big a scale and impact to ignore. We have to ensure that HIV prevention and treatment services are systematically integrated into emergency responses,” said Mr Michel Sidibé, Executive Director of UNAIDS.

The thematic session contemplated the vast and complex issue of HIV in emergency contexts, including the delivery of health and HIV services in the context of conflict situations, natural disasters, public health emergencies, displacement and migration. On protection issues, vulnerability to HIV due to sexual violence, human rights violations, restrictions, punitive laws and policies were topics of discussion. On resilience, participants talked about the need for community building and preparedness.

Panelists from a wide range of countries including Burundi, Central African Republic, Djibouti, Haiti, Lebanon, Liberia, Nepal, Nigeria, Sierra Leone and Ukraine told of the realities on the ground. They spoke of barriers and opportunities and gave examples of successful government and civil society efforts to address HIV in the wide variety of humanitarian emergency contexts.

In his keynote speech, former refugee Mr Noé Seisaba from Burundi, who founded the Stop SIDA organization that brings key HIV initiatives to refugee camps and settings, called for the community of people living with HIV to be involved in all aspects of planning and implementation. “I faced a lot of discrimination, but I broke my silence on HIV to try to make working on HIV a community issue and to show that we can intervene as refugees because we have a true understanding of the challenges and realities,” he said. “I am happy to see we are all talking about this issue, but I want to see concrete action.”

Many participants echoed that community involvement and empowerment of people living with and most affected by HIV are critical to achieve results for people in such difficult contexts. “If we are going to end the AIDS epidemic by 2030, we have to shine light on root causes of vulnerability in humanitarian settings and increase action to promote respect for rights and basic humanitarian dignity,” said Mr George Okoth-Obbo, Assistant High Commissioner for Operations at UNHCR.

Cross-regional strategies were encouraged to enable maximum impact and coverage of people. The challenge of sexual violence in emergency settings and gender inequalities was highlighted as a fundamental issue to be given greater focus, action and investment. 

Feature Story

2015 UNODC World Drug Report: drug use must be addressed as a pressing public health issue

26 June 2015

The use of illicit drugs needs to be understood as a social and health condition requiring sustained prevention, treatment and care. This is one of the major conclusions emerging from the 2015 World Drug Report, published on 26 June by the United Nations Office on Drugs and Crime (UNODC).

Launched to coincide with the International Day against Drug Abuse and Illicit Trafficking, the report gives a detailed snapshot of the latest developments in drug use, production, trafficking and consequences for health. It finds that some 27 million people are dependent on drugs, half of whom inject; that an estimated 1.65 million people who inject were living with HIV in 2013 (around 13.5%) and that women who inject drugs, though fewer in number, are often much more likely to become infected than men.

In a specific chapter on HIV, it is also noted that there is a major issue in access to antiretroviral therapy and harm reduction programmes among people who inject drugs and that only one in six of all users suffering from drug use disorders or drug dependence benefit from such programmes, which include needle and syringe programmes and opioid substitution therapy. The report acknowledges that some progress has been made in lowering HIV transmission among people who inject drugs: newly diagnosed cases of HIV in this group fell by roughly 10% between 2010 and 2013. However, the international community is far off the global target of reducing transmission by 50% by 2015, set in the 2011 United Nations Political Declaration on HIV and AIDS.

The public health implications of illicit drug use highlighted in the report were explored at length during a special briefing in Geneva hosted by UNODC, UNAIDS and World Health Organization (WHO). During the event, UNODC Deputy Executive Director Aldo Lale-Demoz stressed the need for a multipronged approach which goes beyond disrupting criminal networks. “More also needs to be done in promoting the importance of understanding and addressing drug use as a social and health condition requiring sustained prevention, treatment and care,” he said.

Luiz Loures, UNAIDS Deputy Executive Director, stressed that a people-centred approach was required to reach people who use drugs. "We have the knowlege and technology to end the AIDS epidemic but access has been selective. The difference is determined by good or bad policy. Human rights should be guaranteed and health be at the centre of the response."

According to Shekhar Saxena, Director of WHO’s Department of Mental Health and Substance Abuse, national health care systems often lack the capacity to provide effective treatment and care to drug users. He added that WHO would continue to offer guidance and assistance to countries, “to strengthen health-care systems to reach the ultimate goal of the UN Drug Conventions – to protect the health and welfare of humankind.”

People who inject drugs account for some 30% of new HIV infections outside sub-Saharan Africa and two subregions have notably high rates of HIV infection among people who inject drugs: an estimated 29% in south-west Asia and around 23% in eastern and south-eastern Europe—a region with approximately 40% of the global number of such users living with HIV, mainly residing in the Russian Federation and Ukraine.

Feature Story

UNICEF: Millions of children around the globe still left behind

23 June 2015

Despite significant achievements, too many of the world’s poorest children face inequalities that are having a dramatic impact on their health, education and future prospects, warns UNICEF in a report published on 23 June.

In Progress for children: beyond averages, the final report on child-related Millennium Development Goals (MDGs), UNICEF highlights that millions of children and young people are still dying early, missing out on school, living in poverty and being disproportionately affected by the AIDS epidemic.

“The MDGs helped the world realize tremendous progress for children – but they also showed us how many children we are leaving behind,” said UNICEF Executive Director Anthony Lake. “The lives and futures of the most disadvantaged children matter – not only for their own sake, but for the sake of their families, their communities and their societies,” he added.

The report acknowledges that huge strides have been made in attaining MDG 6–combatting HIV/AIDS, malaria and other diseses.  For instance, between 2001 and 2013 new HIV infections have declined by 58% in children under 15, mainly due to progress in the prevention of mother-to-child transmission of HIV. The Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive has helped achieve a rapid expansion in the availability of antiretroviral medicines to pregnant women found to be living with HIV.

However, only 23% of HIV-positive children received such life-saving medicines in 2013 (compared to 37% of adults) and, in addition, adolescents aged 10-19 are the only group that has not seen a decrease in AIDS-related deaths in recent years.

The report also notes that about 35% of the 1.9 million people newly infected with HIV were young people aged 15-24. Adolescent girls are still most affected by HIV and in some countries are two to three times more likely to be infected than their male counterparts.

Progress for Children highlights a number of other such disparities and areas of deep concern across the spheres of health, education and income. It contends that as the era of the MDGs draws to a close, making way for preparations among world leaders to adopt new Sustainable Development Goals, disadvantaged children must be at the heart of these goals and targets.

The report also argues that better data collection, that tells a more rounded story and is not simply reliant on averages such as those used to measure the MDGs, will help identify the most vulnerable children and encourage tailor-made health and education solutions that help them to live longer, happier and healthier lives.

Feature Story

UNHCR: unprecedented levels of forced displacement worldwide

19 June 2015

The number of people and families forced to flee their homes has reached an all-time high, with nearly 60 million people worldwide now displaced by conflict and persecution, says a new report published by the Office of the United Nations High Commissioner for Refugees (UNHCR) for World Refugee Day on 20 June. 

According to UNHCR Global trends 2014, this number is accelerating rapidly. At the end of 2014, some 59.5 million were forcibly displaced, compared to 51.2 million in 2013. Every day last year, an average of 42 500 people became refugees, asylum seekers or internally displaced. This fourfold increase in four years has largely been driven by the war in the Syrian Arab Republic, though numbers are rising across the globe as new conflicts break out or reignite.

In highlighting the unprecedented level of forced displacement and people crossing borders, UNHCR acknowledges that anxiety and intolerance towards them is also growing.  

To address this, the theme of World Refugee Day 2015 is to give a human face to the crisis and show who refugees are and why they need help. By reinforcing the fact that they are ordinary people in extraordinary circumstances, UNHCR hopes to galvanize governments and the public into doing more to improve conditions, empathy and opportunities for people who are forced to move.

United Nations High Commissioner for Refugees António Guterres stressed, "With huge shortages of funding and wide gaps in the global regime for protecting victims of war, people in need of compassion, aid and refuge are being abandoned.” He added, “For an age of unprecedented mass displacement, we need an unprecedented humanitarian response and a renewed global commitment to tolerance and protection for people fleeing conflict and persecution."

A critical part of the UNHCR campaign is to tell the stories of a range of refugees and internally displaced people who are attempting to forge new lives. Several such stories revolve around people living with, or affected by HIV. People who are forcibly displaced may become more vulnerable to HIV as health services become harder to access. They might be more likely to engage in transactional sex if basic needs are not met, and rape is also often used as a weapon of war.

This was the case for Maria Kamwendo, featured by UNHCR, who was raped by rebels in the Democratic Republic of the Congo. She managed to escape and found her way to South Africa. After the shock of being diagnosed as HIV-positive, she has built a new life there and is now an HIV counsellor. “I enjoy what I do,” she says. “HIV is not a death sentence but one can be instrumental in empowering people about the disease.”

By encouraging people to get to know the stories of individual refugees, UNHCR aims to make a link between people lucky enough to have living settled lives and those who are struggling to cope with the trauma of having, through no fault of their own, to flee from their homes.

Feature Story

Global solidarity and national responsibility at work in Zimbabwe

15 June 2015

Zimbabwe has one of the largest HIV epidemics in the world, with an estimated adult HIV prevalence of 15% and 1.4 million people living with HIV. However, the country is accelerating action and increasing investment in its HIV prevention and treatment programmes.

As part of a three-day visit to Zimbabwe, UNAIDS Executive Director Michel Sidibé met with the Vice-President of Zimbabwe, Emmerson Mnangagwa, to discuss the country’s role in the AIDS response. 

During the meeting, Mr Sidibé congratulated the government on progress made in treatment scale-up and prevention, and pointed to the need to Fast-Track the AIDS response to end the epidemic in Zimbabwe by 2030. They talked about securing medicines to keep people living with HIV healthy, as well as the challenges in making sure that adolescent girls are not left behind.

Mr Sidibé also joined the Ministers of Health and Child Care and Finance and Economic Development to discuss with business leaders, civil society and diplomatic missions how to Fast-Track the AIDS response in Zimbabwe.

“The price of medicines has fallen from US$ 10 000 per person per year to under US$ 100,” said Mr Sidibé. “But, to ensure that Africa can deliver a fully sustainable response to HIV, Africa has to start producing its own generic medicines rather than import them from abroad.”

The business leaders present affirmed their commitment to keep investing in the AIDS response even as the country faces severe economic challenges. Pharmaceutical manufacturers pledged to continue looking for ways to be competitive so that the country can play a greater part in the production of antiretroviral and other medicines to lessen its dependence on imports.

The Health Minister, David Parirenyatwa recognized that the AIDS response is a national responsibility. In 2014, Zimbabwe only paid 15% of the response from domestic sources, relying heavily on donor funding to make up the gap. The minister acknowledged that Zimbabwe must do more against stigma and discrimination. Mr Parirenyatwa reaffirmed the government’s commitment to build a concerted strategy to Fast-Track programmes to end the AIDS epidemic by 2030.

To support its response to HIV, in 2000 Zimbabwe introduced an innovative 3% AIDS levy on taxable income. Largely through this levy, domestic financing has increased by 40% in the past three years. To ensure that domestic contributions to Zimbabwe’s response continue to rise, the Minister of Finance, Patrick Chinamasa, said, “Zimbabwe will keep its AIDS levy for the foreseeable future.”

Mr Parirenyatwa said that it is important for Zimbabwe, despite its limited resources, to share a portion of its national trust fund to further the global AIDS response. The government of Zimbabwe presented Mr Sidibé with a cheque for US$ 100 000 to contribute to the UNAIDS core budget for 2015. 

Region/country

Feature Story

Protecting girls and young women in Zimbabwe: a health and human rights matter

12 June 2015

UNAIDS Executive Director Michel Sidibé visited the Mbare City Health Clinic in Harare, Zimbabwe, on 11 June. The public clinic runs an antiretroviral treatment programme that also provides services for victims of rape.

During the visit to the clinic, which is supported by the City of Harare and Médecins sans Frontières, he met people living with HIV, including 19-year-old Thandiwe. Mr Sidibé heard the harrowing story of how she contracted HIV through rape and described her tears as, “A sign of our collective failures. We must do better for her and all women and girls.”

Speaking at the clinic, traditional leader Chief Chiveso denounced violence against women and called on men to be activists against gender-based violence. Mr Sidibé hailed the Chief as a champion for gender equality and for ending gender-based violence and the AIDS epidemic.

Earlier, Mr Sidibé engaged in a dialogue with community leaders, who told him of the challenges that marginalization and unemployment bring. Mr Sidibé said that adolescent girls are affected by the poor economic situation, which has resulted in more girls being infected with HIV compared to their male peers.

Two thirds of the population in Zimbabwe is under 25 years and HIV prevalence is almost two times higher among women aged 15–24 than among men of the same age. Zimbabwe has the sixth highest number of annual adolescent AIDS-related deaths in the world.

Mr Sidibé lauded the combined efforts of Zimbabwe’s civil society and government, which have resulted in a drop in HIV prevalence and the number of AIDS deaths, but warned that the country needs to do more to Fast-Track the response to HIV in order to end the AIDS epidemic in Zimbabwe by 2030. “If we are not careful, after 2015 people will forget about AIDS, complacency will creep in and people will look at other crisis,” he said.

Region/country

Feature Story

Understanding HIV through phylogenetic research

08 June 2015

Phylogenetic research—the analysis of molecular sequencing data to study evolutionary relationships among groups and organisms—needs to be scaled up to end the AIDS epidemic, according to the participants at a symposium held on 4 June at the New York Academy of Sciences called HIV 2015: Using Phylogenetics to Enhance the HIV Response.

Speaking at the symposium, UNAIDS Deputy Executive Director Luiz Loures said that an evidence-driven, focused and rights-based approach is needed to Fast-Track the HIV response in the next five years and end the AIDS epidemic by 2030. “Science has been the major component of the progress we have made so far. Advancing phylogenetics will help us sharpen our focus on the most vulnerable groups, their locations and the progression of the HIV virus,” said Mr Loures.  

Molecular genetics and biodata will provide high-quality information on the diversity of HIV strains among people living with HIV and their evolution and on the dynamics of HIV transmission. “A molecular clock study enables us to identify important characteristics of people transmitting HIV and understand how to reduce high incidence among vulnerable groups, for example young women in Africa,” said Tulio De Oliveira from the Africa Centre and the University of KwaZulu-Natal in Durban, South Africa. “Recent advances in phylogenetic methods and molecular evolution show that data that combine genetic, spatial, immunological and social information can transform our understanding of epidemic dynamics.”

In the past few years, scientists have been closely researching the effectiveness of available antiretroviral medicines and the implications of drug resistance to tailor treatment programmes for specific populations. A phylogenetic study on HIV transmission and drug resistance in 27 areas representing 72% of new diagnosis in the United States of America, among many other findings, showed that 18.9% of men who have sex with men living with HIV transmitted drug resistance mutations between 2010 and 2012. The study also showed higher transmission rates among African-American men who have sex with men and young men who have sex with men. “There is a great opportunity to incorporate phylogenetics and molecular epidemiology into HIV prevention and treatment programmes to improve sustainability,” said Alexa Oster, Lead, Molecular HIV Surveillance at the Division of HIV/AIDS Prevention, Centres for Disease Control and Prevention.  

However, the participants agreed that the significant challenges around genetics and HIV research among key populations, including ethics and human rights issues, will need to be addressed to fully benefit from the potential of phylogenetics.

The annual symposiums convened by the New York Academy of Sciences and UNAIDS bring together scientists, activists, human rights defenders and policy-makers to discuss emerging advances in science relevant to accelerating the HIV response.  

Subscribe to Feature Story